-
HUPO Connect 2020 Industry Seminars
Access to the HUPO Connect 2020 Industry Seminars.
- Total Presentations: 14
-
OD6 - High-Definition Simoa® Biomarker Detection for Precision Monitoring of Disease Progression
- Type: Industry Seminar
- Presentations: 1
- Chair(s): Kevin Hrusovsky
Chair:Kevin Hrusovsky, QuanterixSpeakers:Kevin Hrusovsky, QuanterixSharel Figueredo, PhD, QuanterixPaula Perin, PhD, Quanterix
This discussion will include an overview of the Quanterix mission to promote precision healthcare and unlock proteomics potential through advancements in digital biomarker detection. Attendees will learn how Simoa technology is being used to monitor health and disease progression in the fields of neurology and infectious disease, including COVID-19. We will share data that demonstrate how our immunoassay platforms provide vastly increased sensitivity as compared to alternative multiplex assay technologies.
Industry Seminar Supported By-
OD6.01 - High-Definition Simoa® Biomarker Detection for Precision Monitoring of Disease Progression
Kevin Hrusovsky
Sharel Figueredo
Paula Perin- Presentation
Login or Purchase: To purchase access, please click here to become a member. Already a member, click here to login.
-
OD7 - Unbiased, Deep, Rapid and Scalable Proteomics with the Proteograph™ an Integrated Solution for Unlocking the Proteome
- Type: Industry Seminar
- Presentations: 1
- Chair(s): Juan Cruz Cuevas
Chair:Juan Cruz Cuevas, PhD, Seer, Inc.Speakers:John Blume, PhD, Seer, Inc.Daniel Hornburg, PhD, Seer, Inc.Mark Flory, PhD, Oregon Health Sciences University
For decades, a critical limiting factor in proteomics has been the inability to access the proteome in an unbiased, deep manner, rapidly and at the scale necessary to survey and understand its diversity. To create a more transformative view of the proteome, we had to create a new technology; one that provides a new lens on the proteome, enabling researchers to see the breadth, depth and dynamic nature of proteome diversity across populations and time. This is done across orders of magnitude of protein abundance; and is applicable to longitudinal population studies in a rapid and robust manner. While technologies exist today that can provide one or more of these attributes, the Proteograph will be the first to combine them all into a single, efficient workflow.
This recorded event will cover:• The current challenges in scaling proteomics• A novel approach for unlocking the proteome• How the Proteograph demonstrates the power of this approach vs fractionation methods• An overview of the Proteograph workflow
The Proteograph™ Product Suite is an integrated solution that includes consumables, automation and software. It is designed to deliver the ease of use, efficiency, robustness, and reproducibility needed to tackle proteomic studies of varying sizes with confidence. The Proteograph workflow is optimized for multiple samples in a single run to survey thousands of proteins with precision in approximately seven hours.
Download the Nature Communications paper referenced in the presentation.
Visit www.seer.bio to learn more. Email info@seer.bio for more questions.Industry Seminar Supported ByShow more-
OD7.01 - Unbiased, Deep, Rapid and Scalable Proteomics with the Proteograph™ – an Integrated Solution for Unlocking the Proteome
John Blume
Daniel Hornburg
Mark Flory- Presentation
Login or Purchase: To purchase access, please click here to become a member. Already a member, click here to login.
-
OD8 - Enabling Quantitative Proteomics by Improved Peptide Identifications
- Type: Industry Seminar
- Presentations: 1
- Chair(s): Claire Dauly
Chair:Claire Dauly, Manager Sales Support LSMS ‘OMICS’ Europe, Thermo Fisher ScientificSpeakers:Khatereh Motamedchaboki, Thermo Fisher ScientificProf. Dr. Bernhard Küster, Technical University of Munich
These presentations will describe some of the latest developments to advance proteomics research using innovative Orbitrap mass spectrometry Hardware and Prosit Software Solutions. The latest Thermo Scientific™ Orbitrap Exploris™ 240 mass spectrometer offers leading performance with compact, simplicity and intelligent data acquisition. Posit is a deep neural network developed by the Kuster Lab at TUM to predict iRT values and MS2 spectra for given peptide sequences leading to improved identifications and lower false discovery rates.Industry Seminar Supported ByShow more-
OD8.01 - Enabling Quantitative Proteomics by Improved Peptide Identifications
Khatereh Motamedchaboki
Bernhard Küster- Presentation
Login or Purchase: To purchase access, please click here to become a member. Already a member, click here to login.
-
OD9 - The future of biomarker discovery: A novel approach to plasma proteomics
- Type: Industry Seminar
- Presentations: 1
Speakers:Matthew E.K. Chang, PhD. Oregon Health Sciences University
Ryan W. Benz, PhD. Seer Inc.
Margaret Donovan, PhD. Seer Inc.
Individual Presentations and Speakers:
• Proteomic Biomarker Discovery and the Importance of High-Quality Study Design
Matthew E.K. Chang, PhD. Oregon Health Sciences University• A Novel Combinations of Known/Unknown Candidate Biomarker Profiling in an Alzheimer Plasma Study with Proteograph™ Product Suite
Ryan W. Benz, PhD. Seer Inc.• Unbiased, Deep, and Peptide-Centric Plasma Proteomics at Scale: Enabling Proteogenomic Study of Non-small Cell Lung Cancer
Margaret Donovan, PhD. Seer Inc.For more information on Seer’s Proteograph Product Suite, visit our website at https://seer.bio.
Industry Seminar Supported ByShow more-
The future of biomarker discovery: A novel approach to plasma proteomics (View Presentation)
- Presentation
Login or Purchase: To purchase access, please click here to become a member. Already a member, click here to login.